{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:49:15Z","timestamp":1751554155502,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OARRR"],"DOI":"10.2147\/oarrr.s179704","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:03:46Z","timestamp":1543251826000},"page":"151-160","source":"Crossref","is-referenced-by-count":10,"title":["Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)"],"prefix":"10.2147","volume":"Volume 10","author":[{"given":"Mustafa","family":"Acar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-1665","authenticated-orcid":true,"given":"Prabhjot","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3936-5301","authenticated-orcid":true,"given":"Malcolm","family":"Handel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11]]},"container-title":["Open Access Rheumatology: Research and Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=46562","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=46562","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:03:47Z","timestamp":1543251827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/treatment-persistence-of-subcutaneous-tnf-inhibitors-among-australian--peer-reviewed-article-OARRR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/oarrr.s179704","relation":{},"ISSN":["1179-156X"],"issn-type":[{"type":"electronic","value":"1179-156X"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}